Histone deacetylase 3 modulates the expansion of human hematopoietic stem cells

Stem Cells and Development

Volumn 21, Issue 14, 2012, Pages 2581-2591

  Elizalde, Carina ^a   Fernandez Rueda, Jon ^a   Salcedo, Juan Manuel ^a   Dorronsoro, Akaitz ^a   Ferrin, Izaskun ^a   Jakobsson, Emma ^a   Trigueros, Cesar ^a  

^a Mesenchymal and Hematopoietic Stem Cell Laboratory   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 3; VALPROIC ACID;

ARTICLE; CD34 SELECTION; CELL CYCLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; COLONY FORMING UNIT; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MONOCYTE MACROPHAGE PRECURSOR CELL; PRIORITY JOURNAL; STEM CELL EXPANSION; UMBILICAL CORD BLOOD;

ANTIGENS, CD34; CELL DIFFERENTIATION; CELL DIVISION; CELL LINEAGE; CELL PROLIFERATION; FETAL BLOOD; FLOW CYTOMETRY; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HEMATOPOIETIC STEM CELLS; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HUMANS; LENTIVIRUS; MONOCYTES; RNA, SMALL INTERFERING; VALPROIC ACID;

EID: 84866255190     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0698     Document Type: Article

References (34)

1. Conneally E, J Cashman, A Petzer and C Eaves. (1997). Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci (USA) 94:9836.
2. Kelly SS, CB Sola, M de Lima and E Shpall. (2009). Ex vivo expansion of cord blood. Bone Marrow Transplant 44:673-681.
3. Metcalf D. (2007). Concise review: hematopoietic stem cells and tissue stem cells: current concepts and unanswered questions. Stem Cells 25:2390-2395. (Pubitemid 47582731)
4. Ishikawa F, M Yasukawa, B Lyons, S Yoshida, T Miyamoto, G Yoshimoto, T Watanabe, K Akashi, LD Shultz and M Harada. (2005). Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chainnull mice. Blood 106:1565.
5. Majeti R, CY Park and IL Weissman. (2007). Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell 1:635-645. (Pubitemid 350215330)
6. Vanheusden K, S Van Coppernolle, M De Smedt, J Plum and B Vandekerckhove. (2007). In vitro expanded cells contributing to rapid severe combined immunodeficient repopulation activity are CD34 + 38-33 + 90 + 45RA. Stem Cells 25:107-114. (Pubitemid 46052980)
7. Bug G, H Gul, K Schwarz, H Pfeifer, M Kampfmann, X Zheng, T Beissert, S Boehrer, D Hoelzer, OG Ottmann and M Ruthardt. (2005). Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells. Cancer Res 65: 2537-2541. (Pubitemid 40490047)
8. De Felice L, C Tatarelli, MG Mascolo, C Gregorj, F Agostini, R Fiorini, V Gelmetti, S Pascale, F Padula, et al. (2005). Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells. Cancer Res 65:1505-1513. (Pubitemid 40270180)
9. Tunnicliff G. (1999). Actions of sodium valproate on the central nervous system. J Physiol Pharmacol 50:347-365. (Pubitemid 29473097)
10. Johannessen CU. (2000). Mechanisms of action of valproate: a commentatory. Neurochem Int 37:103-110. (Pubitemid 30254142)
11. Santini V, A Gozzini and G Ferrari. (2007). Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application. Curr Drug Metab 8:383-393.
12. Kramer OH, P Zhu, HP Ostendorff, M Golebiewski, J Tiefenbach, MA Peters, B Brill, B Groner, I Bach, T Heinzel and M Gottlicher. (2003). The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. Embo J 22:3411-3420. (Pubitemid 36834871)
13. Santos-Rosa H and C Caldas. (2005). Chromatin modifier enzymes, the histone code and cancer. Eur J Cancer 41:2381-2402. (Pubitemid 41540617)
14. Davie JR and VA Spencer. (2001). Signal transduction pathways and the modification of chromatin structure. Prog Nucleic Acid Res Mol Biol 65:299-340.
15. Huang W, S Zhao, S Ammanamanchi, M Brattain, K Venkatasubbarao and JW Freeman. (2005). Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex. J Biol Chem 280:10047-10054. (Pubitemid 40395856)
16. Luo J, M Li, Y Tang, M Laszkowska, RG Roeder and W Gu. (2004). Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc Natl Acad Sci (USA) 101:2259-2264. (Pubitemid 38269299)
17. Marzio G, C Wagener, MI Gutierrez, P Cartwright, K Helin and M Giacca. (2000). E2F family members are differentially regulated by reversible acetylation. J Biol Chem 275:10887-10892. (Pubitemid 30212722)
18. Wiznerowicz M and D Trono. (2003). Conditional suppression of cellular genes: lentivirus vector-mediated druginducible RNA interference. J Virol 77:8957-8961. (Pubitemid 36936105)
19. Carcamo-Orive I, A Gaztelumendi, J Delgado, N Tejados, A Dorronsoro, J Fernandez-Rueda, DJ Pennington and C Trigueros. (2010). Regulation of human bone marrow stromal cell proliferation and differentiation capacity by glucocorticoid receptor and AP-1 crosstalk. J Bone Miner Res 25: 2115-2125.
20. Ishizuka T and MA Lazar. (2003). The N-CoR/histone deacetylase 3 complex is required for repression by thyroid hormone receptor. Mol Cell Biol. 23:5122.
21. Doulatov S, F Notta, K Eppert, LT Nguyen, PS Ohashi and JE Dick. (2010). Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. Nat Immunol 11:585-593.
22. Mayani H, W Dragowska and PM Lansdorp. (1993). Characterization of functionally distinct subpopulations of CD34 + cord blood cells in serum-free long-term cultures supplemented with hematopoietic cytokines. Blood 82:2664-2672. (Pubitemid 23318072)
23. Mayani H, W Dragowska and PM Lansdorp. (1993). Cytokine-induced selective expansion and maturation of erythroid versus myeloid progenitors from purified cord blood precursor cells. Blood 81:3252-3258. (Pubitemid 23172906)
24. Krause DS, MJ Fackler, CI Civin and WS May. (1996). CD34: structure, biology, and clinical utility. Blood 87:1-13. (Pubitemid 26018389)
25. Nakamura Y, K Ando, J Chargui, H Kawada, T Sato, T Tsuji, T Hotta and S Kato. (1999). Ex vivo generation of CD34( + ) cells from CD34(-) hematopoietic cells. Blood 94:4053-4059.
26. Danet GH, HW Lee, JL Luongo, MC Simon and DA Bonnet. (2001). Dissociation between stem cell phenotype and NOD/ SCID repopulating activity in human peripheral blood CD34( + ) cells after ex vivo expansion. Exp Hematol 29:1465-1473. (Pubitemid 34007622)
27. Shih CC, MC Hu, J Hu, J Medeiros and SJ Forman. (1999). Long-term ex vivo maintenance and expansion of transplantable human hematopoietic stem cells. Blood 94:1623-1636. (Pubitemid 29411312)
28. Gul H, LA Marquez-Curtis, N Jahroudi, J Lo, AR Turner and A Janowska-Wieczorek. (2009). Valproic acid increases CXCR4 expression in hematopoietic stem/progenitor cells by chromatin remodeling. Stem Cells Dev 18:831-838.
29. Seet LF, E Teng, YS Lai, J Laning, M Kraus, S Wnendt, S Merchav and SL Chan. (2009). Valproic acid enhances the engraftability of human umbilical cord blood hematopoietic stem cells expanded under serum-free conditions. Eur J Haematol 82:124-132.
30. Donaldson C, P Denning-Kendall, B Bradley and J Hows. (2001). The CD34( + )CD38(neg) population is significantly increased in haemopoietic cell expansion cultures in serum-free compared to serum-replete conditions: dissociation of phenotype and function. Bone Marrow Transplantat 27:365-371. (Pubitemid 32201344)
31. Dorrell C, OI Gan, DS Pereira, RG Hawley and JE Dick. (2000). Expansion of human cord blood CD34( +)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function. Blood 95:102-110. (Pubitemid 30017232)
32. Szulc J, M Wiznerowicz, MO Sauvain, D Trono and P Aebischer. (2006). A versatile tool for conditional gene expression and knockdown. Nat Methods 3:109-116. (Pubitemid 43173309)
33. Chaurasia P, D Berenzon and R Hoffman. (2011). Chromatin-modifying agents promote the ex vivo production of functional human erythroid progenitor cells. Blood 117:4632-4641.
34. Bartels M, CR Geest, M Bierings, M Buitenhuis and PJ Coffer. (2010). Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation. Haematologica 95:1052-1060.